Immunis, Inc.

Biotechnology company · Irvine, California, United States

Immunis, Inc. is a biotechnology company headquartered in Irvine, California, United States. It has reported private securities offerings to the US SEC, most recently $12 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Immunis at a glance

Typebiotechnology company

HeadquartersIrvine, California, United States

SEC CIK2028798

What does Immunis do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $12 million sold (2026).

Frequently asked questions about Immunis

Where is Immunis headquartered?

Immunis, Inc. is headquartered in Irvine, California, United States.

What does Immunis do?

Immunis, Inc. is a biotechnology company.

Similar companies

AiVita Biomedical, Inc.Irvine, California, United States
Celestial Therapeutics Inc.Irvine, California, United States
Tarsus Pharmaceuticals, Inc.Irvine, California, United States
Cloudbreak Therapeutics LLCIrvine, California, United States
Praxis Bioresearch IncIrvine, California, United States
Nuravax, Inc.Irvine, California, United States
AcuFocus, Inc.Irvine, California, United States
PeproMene Bio, Inc.Irvine, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences